1. Introduction {#sec1}
===============

The term*insulin resistance* (IR) was coined in 1936 to describe a metabolic disturbance characterized by decreased cellular responsiveness to insulin signaling in insulin-dependent tissues such as skeletal muscle, liver, and adipose tissue \[[@B1]\]. IR has now been established to play a key role in pancreatic *β* cell dysfunction and type 2 diabetes mellitus (DM2) \[[@B2]\]. This disease represents one of the leading causes of mortality in the adult population worldwide \[[@B3]\], with alarming projections for the future, with an estimated prevalence of 33% in adults in the USA by 2050 \[[@B4]\]. Furthermore, IR is a fundamental pathophysiologic component of several other endocrine-metabolic disorders, such as hypertension, dyslipidemias, polycystic ovary syndrome, metabolic syndrome, and cardiovascular disease \[[@B5], [@B6]\].

In light of the great morbidity and mortality rates associated with these disorders, prominent scientific effort has been directed to the refinement of tools for the detection and assessment of IR. In this regard, HOMA2-IR \[[@B7]\] stands as one of the most broadly accepted models in research settings yet remains relatively underutilized in our local clinical scenario. In this context, previous analyses by our research group have estimated specific cutoffs for this variable in our population \[[@B8]\], laying the groundwork for their potential clinical and epidemiologic use.

IR is intimately linked with psychobiologic habits such as smoking, alcohol consumption, hypercaloric diets, and physical inactivity. In turn, these factors can be strongly conditioned by demographic, social, and economic aspects, which shape daily human living. Thus, the objective of this study was to determine the prevalence and determinants of IR in the adult population of Maracaibo city, Venezuela.

2. Materials and Methods {#sec2}
========================

2.1. Sample Selection {#sec2.1}
---------------------

This report is part of the Maracaibo City Metabolic Syndrome Prevalence Study, a cross-sectional study whose purpose is to identify MS and cardiovascular risk factors in the adult population of Maracaibo, the second largest city of Venezuela. The sample (1,986 individuals) was calculated based on estimations of the city\'s population by our National Institute of Statistics (1,428,043 inhabitants for the year 2007). A total of 244 subjects (12%) were added for oversampling, in order to increase accuracy of the estimates obtained from smaller subgroups from the overall sample, amounting to a total of 2,230 individuals. Maracaibo city is divided into parishes, each of which was proportionally sampled with a multistaged cluster method: In the first stage, clusters were represented by sectors from each of the 18 parishes, selecting 4 from each parish by simple randomized sampling. In the second phase, clusters were represented by city blocks within each sector, which were selected by simple randomized sampling using a random number generation tool. Further details of the sampling process have been previously published elsewhere \[[@B9]\].

2.2. Ethical Considerations {#sec2.2}
---------------------------

All participants signed written consent prior to undergoing physical examination and blood sample collection. All procedures were approved by the Ethics Committee of the Endocrine and Metabolic Diseases Research Center of The University of Zulia, Maracaibo, Venezuela.

2.3. Subject Evaluation {#sec2.3}
-----------------------

Data were collected through completion of a full clinical record carried out by trained personnel, which encompassed interrogation regarding ethnic origin, marital status (single, married, cohabiting, or divorced), occupational status (employed or unemployed), and educational status, under the following definitions: (a) illiterate, subjects with no reading or writing skills; (b) primary education, those who attended or finished primary or middle school; (c) secondary education, those who attended or finished high school; and (d) high education, those who attended or finished college/university \[[@B9]\]. Socioeconomic status was assessed with the Graffar scale modified by Méndez-Castellano for the Venezuelan population \[[@B10]\]. This tool allows stratification of the population according to four variables: occupation of the head of household, educational level of the subject\'s parents, income source, and housing conditions. Each of these items is rated in a Likert-type scale from 1 to 5 (1 representing the best possible scenarios and 5 the worst). The scores for each item are tallied into a total integrated score ranging from 4 to 20 points, categorized as follows: Stratum I or High Class (4--6 points); Stratum II or Middle-High Class (7--9 points); Stratum III or Middle Class (10--12 points); Stratum IV or Relative Poverty (13--16 points), and Stratum V or Critical Poverty (17--20 points).

### 2.3.1. Smoking Habit {#sec2.3.1}

Based on information obtained during the clinical interview, subjects were categorized by their smoking habits as follows \[[@B11]\]: (a) nonsmokers, individuals who had never smoked or had smoked \<100 cigarettes in their lifetime; (b) current smokers, subjects who had smoked ≥100 cigarettes in their lifetime or reported current habitual smoking at the time of evaluation or had quit smoking less than one year prior to our assessment; and (c) past smokers, individuals who had consumed ≥100 cigarettes in their lifetime and quit over one year prior to our questioning.

### 2.3.2. Alcohol Consumption {#sec2.3.2}

For the assessment of alcohol intake, subjects were asked to estimate the amount of alcoholic drinks they consumed within a month, with the approximate quantity and frequency of daily intake for each type of drink: beer, spirits, and wine and its derivatives. Accounting for the standard content of alcohol grams in each kind of beverage \[[@B12]\], daily intake of alcohol grams was calculated through the following formula \[[@B13]\]: $$\begin{matrix}
{\frac{\text{Daily\ consumed\ (mL)} \times \text{degrees\ of\ alcohol} \times 0.8}{100},} \\
\end{matrix}$$where 0.8 is a constant representing ethanol density in drinks. Based on this estimation, drinkers were defined as subjects who consumed ≥1 gram of alcohol daily \[[@B14]\].

### 2.3.3. Physical Activity {#sec2.3.3}

Physical activity (PA) was assessed with the International Physical Activity Questionnaire (IPAQ) \[[@B15]\]. For statistical analysis, PA was evaluated in 4 domains: occupational, household, transport, and leisure. In each of these domains, subjects were categorized as follows: (a) inactive, MET/week = 0, or (b) active, MET/week \>0. The latter were then subcategorized by gender-specific MET/week quintiles in each domain ([Table 1](#tab1){ref-type="table"}).

### 2.3.4. Blood Pressure {#sec2.3.4}

Blood pressure (BP) was taken with subjects sitting down with their feet on the floor following 15 minutes of rest, determined through the auscultatory method with a calibrated mercury sphygmomanometer, identifying Korotkoff\'s phases I and V as systolic and diastolic BP, respectively. BP was determined 3 times, with 15 minutes in between each take, on two different days; results were classified by the Eighth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-8) guidelines \[[@B16]\].

### 2.3.5. Anthropometry {#sec2.3.5}

An electrical bioelectric scale was used to obtain weight (Tanita, TBF-310 GS Body Composition Analyzer, Tokyo, Japan). Height was measured using a calibrated metric measurement tape, with the subject standing up barefoot. Body Mass Index (BMI) was calculated with the following formula: \[weight/height^2^\] expressing results as kg/m^2^. According to their BMI, subjects were sorted in 3 categories: (a) BMI ≤ 24.9; (b) 25--29.9; and (c) ≥30 \[[@B17]\]. Waist circumference (WC) was evaluated with calibrated measuring tapes in accordance with the anatomical landmarks proposed by the USA National Institutes of Health protocol \[[@B18]\].

### 2.3.6. Laboratory Analysis {#sec2.3.6}

Overnight fasting determination of glucose, total cholesterol, triacylglycerides (TAG), and HDL-C was done with an automated analyzer (Human Gesellschaft für Biochemica und Diagnostica mbH, Germany); the intra-assay variation coefficients for total cholesterol, TAG, and HDL-C were 3%, 5%, and 5%, respectively. LDL-C and VLDL-C levels were calculated applying Friedewald\'s formula \[[@B19]\] but when TAG levels were \<400 mg/dL. LDL-C concentrations were directly measured through lipoprotein electrophoresis and densitometry with a BioRad GS-800 optical densitometer. Insulin was quantified using ultrasensitive ELISA double-sandwich methodology (DRG Instruments GmbH, Germany, Inc.).

### 2.3.7. Diagnosis of Metabolic Syndrome {#sec2.3.7}

The metabolic syndrome was defined by the criteria from the IDF/NHLBI/AHA/WHF/IAS/IASO-2009 consensus \[[@B20]\], which require the presence of ≥3 of the following components: (a) low HDL-C, \<50 mg/dL in females or \<40 mg/dL in males; (b) high TAG, ≥150 mg/dL; (c) elevated WC, ≥80 cm in females or ≥90 cm in males; (d) hyperglycemia, fasting glycemia ≥100 mg/dL or personal history of type 2 diabetes mellitus or prescription of hypoglycemic drugs; and (e) High Blood Pressure, BP ≥130/85 mm/Hg or previously diagnosed hypertension or prescription of antihypertensive drugs.

### 2.3.8. Assessment of Insulin Resistance {#sec2.3.8}

HOMA2-IR was utilized for the evaluation of IR as proposed by Levy et al. \[[@B21]\], computed with the HOMA-Calculator version 2.2.2 software application. IR was defined as HOMA2-IR ≥ 2 \[[@B8]\].

2.4. Statistical Analysis {#sec2.4}
-------------------------

Qualitative variables were expressed as absolute and relative frequencies, evaluating association through Pearson\'s Chi-squared (*χ* ^2^) test, while the *Z* test for proportions was used to assess differences between proportions. Quantitative variables were evaluated for distribution normality with Geary\'s test and were expressed as arithmetic means ± SD. Variables with nonnormal distribution underwent logarithmic transformation; when normalization could not be achieved, these variables were expressed as medians (25th percentile--75th percentile). Student\'s *t*-test or Mann-Whitney\'s *U* tests were applied to evaluate differences between means or medians, respectively.

A multiple logistic regression model was constructed in order to estimate odds ratios (confidence interval 95%) for the presence of IR, adjusted by gender, age groups, ethnic groups, socioeconomic status, educational status, marital status, occupational status, smoking habits, leisure-domain PA, glycemic status, presence of high TAG, presence of low HDL-C, JNC-8 classification, presence of elevated WC, and BMI classification. Data were analyzed with the Statistical Package for the Social Sciences (SPSS) version 21 for Windows (IBM Inc., Chicago, IL), and the results were considered statistically significant when *p* \< 0.05.

3. Results {#sec3}
==========

3.1. Characteristics of the General Population {#sec3.1}
----------------------------------------------

The sociodemographic and psychobiologic features of the sample are summarized in [Table 2](#tab2){ref-type="table"}, while metabolic and anthropometric aspects are presented in [Table 3](#tab3){ref-type="table"}. A total of 2026 individuals were studied: 52.10% (*n* = 1056) females and 47.90% (*n* = 970) males. The mean age was 39.69 ± 15.37 years (41.06 ± 15.68 years for women, 38.20 ± 14.89 years for men).

3.2. HOMA2-IR by Gender and Age Groups {#sec3.2}
--------------------------------------

The prevalence of IR was 46.5% (*n* = 943) in the general population, with 46.7% (*n* = 493) in women and 46.4% (*n* = 450) in men (*χ* ^2^ = 0.018; *p* = 0.895) ([Figure 1(a)](#fig1){ref-type="fig"}). On the other hand, [Figure 1(b)](#fig1){ref-type="fig"} illustrates the prevalence of IR by age groups: A significantly greater proportion of IR was found in the groups aged 30--59 years (49.7%, *n* = 559) and ≥60 years (49.8%, *n* = 114), in comparison to individuals aged \<30 years (40.1%, *n* = 270) (*χ* ^2^ = 16.726; *p* = 2.33 × 10^−4^).

3.3. HOMA2-IR and Other Sociodemographic Factors {#sec3.3}
------------------------------------------------

When assessing the epidemiologic behavior of IR according to sociodemographic factors ([Table 4](#tab4){ref-type="table"}), an association was found only in regard to marital status (*χ* ^2^ = 17.293, *p* = 0.001), with a significantly greater proportion of IR subjects among married individuals (51.5% versus 48.5% individuals with HOMA2-IR \< 2).

3.4. HOMA2-IR and Psychobiologic Habits {#sec3.4}
---------------------------------------

Regarding smoking habits ([Figure 2(a)](#fig2){ref-type="fig"}), no link was found with the presence of IR (*χ* ^2^ = 6.575; *p* = 0.37). Nevertheless, we observed a greater proportion of IR subjects among past smokers (51.9% versus 48.1% without IR; *p* \< 0.05). Conversely, the absence of IR was prevalent among nonsmokers (55.2% versus 44.8% with IR; *p* \< 0.05). With respect to alcohol intake and IR ([Figure 2(b)](#fig2){ref-type="fig"}), no statistically significant association was found (*χ* ^2^ = 3.969; *p* = 0.46). Similarly, no link was ascertained between IR and PA in the home (*χ* ^2^ = 2.27; *p* = 0.81), work (*χ* ^2^ = 1.82; *p* = 0.87), and transport (*χ* ^2^ = 8.60; *p* = 0.12) domains ([Table 5](#tab5){ref-type="table"}). However, a significant association was ascertained between the presence of IR and leisure-domain PA (*χ* ^2^ = 23.24;  *p* = 0.003), with a higher proportion of non-IR individuals in the high and very high PA categories in this domain (61.3%, *n* = 92 and 65.5%, *n* = 110, resp., versus IR subjects; *p* \< 0.05).

3.5. HOMA2-IR and Metabolic Characteristics {#sec3.5}
-------------------------------------------

The presence of HOMA2-IR ≥ 2 was found to be associated with various metabolic characteristics ([Table 6](#tab6){ref-type="table"}), being significantly more prevalent among subjects with BMI ≥ 30 kg/m^2^ (68.8% versus 31.2% in subjects without IR; *p* \< 0.05), high TAG (62.8% versus 37.2%; *p* \< 0.05), low HDL-C (52.5% versus 47.5%; *p* \< 0.05), elevated WC (67.7% versus 36.3%; *p* \< 0.05), hypertension (57.9% versus 42.1%; *p* \< 0.05), impaired fasting glucose (37.6% versus 62.4%; *p* \< 0.05), and DM2 (78.7% versus 21.3%; *p* \< 0.05).

3.6. HOMA2-IR and Biologic and Anthropometric Variables {#sec3.6}
-------------------------------------------------------

[Table 7](#tab7){ref-type="table"} displays the behavior of several biologic and anthropometric characteristics by IR status. Individuals with this disorder had significantly higher age (*p* = 3.15 × 10^−5^), BMI (*p* = 13 × 10^−5^), WC (*p* = 4.49 × 10^−54^), fasting blood glucose (*p* = 3.41 × 10^−39^), systolic BP (*p* = 2.33 × 10^−8^), diastolic BP (*p* = 2.93 × 10^−11^), and hs-CRP (*p* = 4.51 × 10^−7^) than the non-IR population. A similar pattern was found regarding serum lipids, especially TAG (154.48 ± 122.02 versus 110.70 ± 76.27; IR and non-IR subjects, *p* = 5.45 × 10^−29^) and HDL-C, which was significantly lower in IR individuals (41.97 ± 10.95 versus 45.90 ± 12.58; *p* = 3.67 × 10^−14^).

3.7. Risk Factors for Insulin Resistance in Maracaibo City {#sec3.7}
----------------------------------------------------------

The risk factors for the presence of IR in our population are shown in [Table 8](#tab8){ref-type="table"}. Following adjustment of the multivariate model, the age groups of 30--59 years (OR: 0.65, CI 95%: 0.50--0.85; *p* \< 0.01) and ≥60 years (OR: 0.42, CI 95%: 0.28--0.65; *p* \< 0.01) were associated with lower odds of IR. On the other hand, the female gender (OR: 1.29, CI 95%: 1.02--1.65; *p* = 0.04) and employed occupational status (OR: 1.45, CI 95%: 1.15--1.83; *p* \< 0.01) were linked with higher risk of IR. The sole psychobiologic factor independently related to IR was alcohol intake (OR: 1.41, CI 95%: 1.10--1.79; *p* \< 0.01). Similarly, high TAG (OR: 1.77, CI 95%: 1.38--2.27; *p* \< 0.01), low HDL-C (OR: 1.31, CI 95%: 1.06--1.64; *p* = 0.01), and BMI ≥30 kg/m^2^ (OR: 4.33, CI 95%: 2.97--6.29; *p* \< 0.01), as well as impaired fasting glucose and DM2, were also associated with increased odds of IR in our population. Furthermore, no relevant differences were revealed after adjustment of a second model with exclusion of diabetic subjects.

4. Discussion {#sec4}
=============

In recent years, a myriad of biologic, psychological, sociodemographic, and economic factors have driven the*epidemiologic transition*, which features a shift in the major worldwide causes of mortality from infectious diseases to chronic-degenerative disorders \[[@B22]\]. This group includes cardiovascular disease and DM2, where IR plays a fundamental role in their pathophysiology, in close association with Westernized lifestyles such as physical inactivity and hypercaloric diets \[[@B1]\]. Thus, detection and management of this condition have become a priority in primary care. Nevertheless, its epidemiologic behavior remains incompletely elucidated in many populations, including our locality.

We found the prevalence of IR in Maracaibo to be relatively elevated, in harmony with other reports within our country, 54.8% in Valencia city \[[@B23]\], 50.6% in a community from Tinaquillo \[[@B24]\], and up to 61.2% in a Canarian-Venezuelan population \[[@B25]\]. This may be explained by the growing prevalence of obesity and other cardiovascular risk factors in Venezuela \[[@B26]\], as well as methodological limitations and heterogeneity.

Moreover, IR prevalence is widely variable across demographics: whereas European populations appear to boast lower prevalence of IR, estimated at 17% in a Danish study, for example, \[[@B27]\], it has been reported to be as high as 51% in Iran, West Asia \[[@B28]\]. On the other hand, IR prevalence has been estimated at 39.1% in Hispanic subjects residing in Texas, USA \[[@B29]\]. Indeed, differing genetic, epigenetic, and sociocultural factors are important determinants of insulin sensitivity \[[@B30], [@B31]\]. In addition, utilization of IR-assessing methods different from HOMA2-IR or arbitrary cutoffs may also contribute to these disparities \[[@B32]\].

In our sample, IR prevalence was similar between genders, diverging from findings in a Danish population \[[@B27]\] and the*Framingham Heart Study* \[[@B33]\], where men showed a higher prevalence, ostensibly attributed to the protective role of estrogens in the development of IR \[[@B34]\]. However, in our study, multivariate analysis revealed women to be at greater risk of IR, echoing a previous report by Rojas et al. \[[@B35]\] on subjects with acute coronary syndrome from Maracaibo. Furthermore, it should be noted that, in this study, the average age in females was 41 years, when a progressive decline in ovarian function tends to begin in most women \[[@B36]\]. In addition, females older than this average age displayed greater prevalence of DM2 and physical inactivity than their male counterparts; these factors favor endocrine-metabolic aging \[[@B37]\] which may explain our findings.

Indeed, aging has been closely linked with IR, chiefly due to the loss of lean mass and gain of visceral adiposity seen in this process \[[@B38]\]. Nonetheless, in multivariate analysis, we found individuals aged ≥60 years to have lower odds of IR. In this regard, certain reports have outlined a protective or innocuous role for adiposity in old age, due to reduced lipolytic activity in this tissue \[[@B39]\]. Likewise, in subjects with chronic-degenerative diseases, a BMI ≥ 25 Kg/m^2^ has been reported to be linked with lower mortality, in a phenomenon termed the "obesity paradox" \[[@B40], [@B41]\]. This effect may be responsible for the lower prevalence of IR in our study, as subjects aged ≥60 years exhibited high prevalence of abdominal obesity and comorbidities such as DM2, metabolic syndrome, and hypertension. At any rate, this relationship is very complex with numerous confounding factors, for example, smoking habits, and other comorbidities; therefore, future studies should further explore the interplay between obesity, IR, and old age.

When examining sociodemographic factors, we found marital status to be associated with IR, which was more frequent among married subjects. Notably, a large part of these were male, were inactive, and had elevated BMI and WC, possibly underlying this epidemiologic behavior. This harmonizes with the research by Sobal et al. \[[@B42]\] and Kiadaliri et al. \[[@B43]\] who described married men to have increased risk of overweight and obesity, associated with more frequent and abundant eating and decreased PA. Occupational status also displayed an interesting relationship with IR in our study, with employed individuals having increased odds for this condition. In this context, unemployed subjects exhibited higher leisure-domain PA, along with lower prevalence of elevated WC than their counterparts, in consonance with findings in an Iranian population where unemployment was a protective factor against overweight and obesity \[[@B43]\].

On the other hand, performance of any degree of leisure-domain PA, even under the recommended threshold, has been described to reduce global, cardiovascular, and cancer-related mortality \[[@B44]\], accompanied by a favorable impact on insulin sensitivity and glucose tolerance \[[@B45]\]. We found leisure-domain PA to be a protective factor against IR in males with \>297 MET/week and females with \>231 MET/week; thus, the American Diabetes Association recommendations on PA intensity and quantity may be applicable for prevention of DM2 in Maracaibo \[[@B46]\].

Alcohol consumption was found to be another risk factor for IR in our population. In a previous publication \[[@B14]\], we reported 45% of men and 16.7% of women in Maracaibo to be habitual drinkers; of these, 72.4% and 76.2% were shown to drink approximately 1--4 beers daily with a high prevalence of abdominal obesity in this group. In this respect, a meta-analysis by Bendsen et al. \[[@B47]\] encompassing 35 observational studies and 12 experimental studies determined high beer intake (\>500 mL/day) to be associated with abdominal obesity, which in turn plays a central role in the development of IR.

We also found each of the separate components of the metabolic syndrome to be independently associated with IR, with the exception of hypertension. The relationship with obesity appears most prominent: In our population, BMI ≥ 30 kg/m^2^ grants 4 times greater odds of IR; this link has been extensively demonstrated in several cross-sectional and longitudinal studies \[[@B48], [@B49]\]. Similarly, high TAG has been associated with decreased insulin sensitivity \[[@B50]\], and both this disorder and low HDL-C have been independently linked with IR \[[@B51]\]. However, in our population, the mild association between elevated WC and IR appears to be dependent on the presence of DM2.

As may be expected, we also found high odds of IR in subjects with hyperglycemia; in this state, oxidation of fatty acids is attenuated, favoring their esterification and leading to a subsequent increase in synthesis of adipokines, which disrupt insulin activity and peripheral utilization of glucose \[[@B52]\]. In parallel, hyperglycemia potentiates oxidative stress via activation of the ceramide and diacylglycerol pathways and other intermediaries, which also hinder insulin signaling \[[@B53]\].

Our results show a close relationship between IR and various sociodemographic, psychobiologic, and cardiometabolic factors in our population, highlighting the clinician\'s role in the early detection of this condition. Indeed, regardless of the methods employed \[[@B54]\], identification of subjects at high cardiometabolic risk is a fundamental preventive strategy for reducing the morbidity and mortality of disorders associated with IR.
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###### 

Gender-specific MET quintiles for each domain of physical activity (Maracaibo, Venezuela, 2015).

  ----------------------------------------------------------------------------
  MET quintiles^*∗*^    Females       Males                      
  -------------------- ------------- ------------- ------------- -------------
  Work\                Lower limit   Upper limit   Lower limit   Upper limit
  domain                                                         

                                                                 

  Very low             33.00         385.99        33.00         714.99

  Low                  386.00        1201.49       715.00        2042.09

  Moderate             1201.50       2751.59       2042.10       3578.39

  High                 2751.60       4546.79       3578.40       6495.59

  Very high            4546.80                     4546.80        

                                                                 

  Transport\           Lower limit   Upper limit   Lower limit   Upper limit
  domain                                                         

                                                                 

  Very low             33.00         131.99        33.00         164.99

  Low                  132.00        230.99        165.00        257.49

  Moderate             231.50        346.49        247.50        521.09

  High                 346.50        700.79        521.10        1385.99

  Very high            700.80                      1386.00        

                                                                 

  Household\           Lower limit   Upper limit   Lower limit   Upper limit
  domain                                                         

                                                                 

  Very low             30.00         539.99        30.00         269.99

  Low                  540.00        1139.99       270.00        629.99

  Moderate             1140.00       1919.99       630.00        1084.99

  High                 1920.00       3779.99       1085.00       2429.99

  Very high            3780.00                     2430.00        

                                                                 

  Leisure\             Lower limit   Upper limit   Lower limit   Upper limit
  domain                                                         

                                                                 

  Very low             33.00         230.99        33.00         296.99

  Low                  321.00        445.49        297.00        791.99

  Moderate             445.50        742.49        792.00        1532.39

  High                 742.50        1798.79       1532.40       2879.99

  Very high            1798.80                     2880.00        
  ----------------------------------------------------------------------------

^*∗*^Obtained from IPAQ scoring. Subjects with 0 MET were excluded from quintiles and classified separately as inactive.

###### 

Sociodemographic and psychobiologic characteristics of the population by gender (Maracaibo, Venezuela, 2015).

                                        Females (*n* = 1056)    Males (*n* = 970)    Total (*n* = 2026)                 
  ------------------------------------ ----------------------- -------------------- --------------------- ------ ------ ------
  *Age groups (years)*                                                                                                   
   \<30                                308                     29.2                 365                   37.6   673    33.2
   30--59                              607                     57.5                 517                   53.3   1124   55.5
   ≥60                                 141                     13.4                 88                    9.1    229    11.3
                                                                                                                        
  *Ethnic groups*                                                                                                        
   Mixed                               796                     75.4                 754                   77.7   1550   76.5
   Hispanic white                      175                     16.6                 146                   15.1   321    15.8
   Afro-Venezuelan                     27                      2.6                  33                    3.4    60     3.0
   American Indian                     47                      4.5                  36                    3.7    83     4.1
   Others                              11                      1.0                  1                     0.1    12     0.6
                                                                                                                        
  *Socioeconomic status*                                                                                                 
   Stratum I                           17                      1.6                  19                    2.0    36     1.8
   Stratum II                          179                     17.0                 185                   19.1   364    18.0
   Stratum III                         394                     37.3                 409                   42.2   803    39.6
   Stratum IV                          411                     38.9                 325                   33.5   736    36.3
   Stratum V                           55                      5.2                  32                    3.3    87     4.3
                                                                                                                        
  *Marital status*                                                                                                       
   Single                              445                     42.3                 414                   43.1   859    42.7
   Married                             392                     37.2                 417                   43.4   809    40.2
   Others                              216                     20.5                 130                   13.5   346    17.2
                                                                                                                        
  *Educational status*                                                                                                   
   Illiterate                          25                      2.4                  17                    1.8    42     2.1
   Primary education                   217                     20.5                 103                   10.6   320    15.8
   Secondary education                 466                     44.1                 479                   49.4   945    46.6
   High education                      348                     33.0                 371                   38.2   719    35.5
                                                                                                                        
  *Occupational status*                                                                                                  
   Unemployed                          575                     54.5                 263                   27.1   838    41.4
   Employed                            481                     45.5                 707                   72.9   1188   58.6
                                                                                                                        
  *Smoking habit*                                                                                                        
   Nonsmoker                           792                     75.1                 606                   62.9   1398   69.3
   Current smoker                      119                     11.3                 181                   18.8   300    14.9
   Past smoker                         143                     13.6                 177                   18.4   320    15.9
                                                                                                                        
  *Alcohol intake* ^*∗*^ *(%)*         196                     18.6                 470                   48.5   666    32.9
                                                                                                                        
  *Physical inactivity* ^*∗∗*^ *(%)*   252                     23.9                 443                   45.7   695    34.3

^*∗*^≥1 g of alcohol per day. ^*∗∗*^Based on IPAQ scoring.

###### 

Anthropometric and cardiometabolic characteristics of the population by gender (Maracaibo, Venezuela, 2015).

                                    Females (*n* = 1056)    Males (*n* = 970)    Total (*n* = 2026)                 
  -------------------------------- ----------------------- -------------------- --------------------- ------ ------ ------
  *Body Mass Index (kg/m* ^*2*^)                                                                                     
   ≤24.9                           377                     35.7                 245                   25.3   622    30.7
   25--29.9                        333                     31.5                 386                   39.8   719    35.5
   ≥30                             346                     32.8                 339                   34.9   685    33.8
                                                                                                                    
  *High TAG* ^‡^                                                                                                     
   Absent                          815                     77.2                 644                   66.4   1459   72.0
   Present                         241                     22.8                 326                   33.6   567    28.0
                                                                                                                    
  *Low HDL-C* ^‡^                                                                                                    
   Absent                          384                     36.4                 479                   49.4   863    42.6
   Present                         672                     63.6                 491                   50.6   1163   57.4
                                                                                                                    
  *Elevated WC* ^*∗*^                                                                                                
   Absent                          597                     51.0                 502                   47.4   1099   49.3
   Present                         573                     49.0                 556                   52.6   1129   50.7
                                                                                                                    
  *JNC-8 classification*                                                                                             
   Normotensive                    481                     45.5                 312                   32.2   793    39.1
   Prehypertensive                 381                     36.1                 384                   39.6   765    37.8
   Hypertensive                    194                     18.4                 274                   28.2   468    23.1
                                                                                                                    
  *Glycemic status* ^*¥*^                                                                                            
   Normoglycemic                   775                     73.5                 667                   68.8   1442   71.2
   Impaired fasting glycemia       187                     17.7                 217                   22.4   404    20.0
   Type 2 diabetes mellitus        92                      8.7                  86                    8.9    178    8.8

TAG: triacylglycerides; HDL-C: high-density lipoprotein-cholesterol; WC: waist circumference.

^‡^ *IDF/AHA/NHLBI/WHF/IAS/IASO* 2009 consensus criteria.

^*∗*^Females ≥ 90 cm; males ≥ 95 cm.

^¥^ *ADA* 2014 classification.

###### 

Prevalence of insulin resistance in the general population by sociodemographic variables (Maracaibo, Venezuela, 2015).

                                    HOMA2-IR \< 2    HOMA2-IR ≥ 2   *p* ^*∗*^   *χ* ^2^(*p*)                   
  -------------------------------- ---------------- --------------- ----------- -------------- --------------- -----------------
  *Ethnic group*                                                                               *2.65 (0.61)*   
   Mixed                           837              54.0            713         46.0           NS               
   Hispanic white                  161              50.2            160         49.8           NS               
   Afro-Venezuelan                 33               55.0            27          45.0           NS               
   American Indian                 47               56.6            36          43.4           NS               
   Others                          5                41.7            7           58.3           NS               
                                                                                                               
  *Socioeconomic status*                                                                                       *4.33 (0.36)*
   Stratum I: High Class           18               50.0            18          50.0           NS               
   Stratum II: Middle-High Class   186              51.1            178         48.9           NS               
   Stratum III: Middle Class       445              55.4            358         44.6           NS               
   Stratum IV: Relative Poverty    382              51.9            354         48.1           NS               
   Stratum V: Critical Poverty     52               59.8            35          40.2           NS               
                                                                                                               
  *Marital status*                                                                                             *17.29 (0.001)*
   Single                          503              58.6            356         41.4           \<0.05           
   Married                         392              48.5            417         51.5           \<0.05           
   Others                          181              52.3            165         47.7           NS               
                                                                                                               
  *Educational status*                                                                                         *6.76 (0.079)*
   Illiterate                      27               64.3            15          35.7           NS               
   Primary education               154              48.1            166         51.9           \<0.05           
   Secondary education             521              55.1            424         44.9           NS               
   High education                  381              53.0            338         47.0           NS               
                                                                                                               
  *Occupational status*                                                                                        *3.25 (0.071)*
   Unemployed                      428              51.1            410         48,9           NS               
   Employed                        655              55.1            533         44.9           NS               

NS: nonsignificant; *p* ^*∗*^: *Z* test for proportions; *χ* ^2^: Pearson\'s Chi-squared test.

###### 

Prevalence of insulin resistance in the general population by physical activity domains (Maracaibo, Venezuela, 2015).

  Physical activity pattern    HOMA2-IR \< 2    HOMA2-IR ≥ 2   *p* ^*∗*^   *χ* ^2^(*p*)            
  --------------------------- ---------------- --------------- ----------- -------------- -------- -----------------
  *Work domain*                                                                                    *1.82 (0.87)*
   Inactive                   799              53.1            706         46.9           NS        
   Very low                   56               53.8            48          46.2           NS        
   Low                        63               58.9            44          41.1           NS        
   Moderate                   52               51.0            50          49.0           NS        
   High                       54               52.9            48          47.1           NS        
   Very high                  59               55.7            47          44.3           NS        
                                                                                                   
  *Transport domain*                                                                               *8.60 (0.12)*
   Inactive                   359              49.3            369         50.7           NS        
   Very low                   129              56.3            100         43.7           NS        
   Low                        147              56.1            115         43.9           NS        
   Moderate                   142              55.5            114         44.5           NS        
   High                       161              57.1            121         42.9           NS        
   Very high                  132              54.8            109         45.2           NS        
                                                                                                   
  *Household domain*                                                                               *2.27 (0.81)*
   Inactive                   295              52.2            270         47.8           NS        
   Very low                   151              55.7            120         44.3           NS        
   Low                        160              53.5            139         46.5           NS        
   Moderate                   172              56.2            134         43.8           NS        
   High                       148              52.5            134         47.5           NS        
   Very high                  157              51.8            146         48.2           NS        
                                                                                                   
  *Leisure domain*                                                                                 *23.24 (0.003)*
   Inactive                   612              50.0            613         50.0           NS        
   Very low                   79               50.3            78          49.7           NS        
   Low                        98               57.6            72          42.4           NS        
   Moderate                   92               59.0            64          41.0           NS        
   High                       92               61.3            58          38.7           \<0.05    
   Very high                  110              65.5            58          34.5           \<0.05    

NS: nonsignificant; *χ* ^2^: Pearson\'s Chi-squared test; *p* ^*∗*^: *Z* test for proportions.

###### 

Prevalence of insulin resistance in the general population by metabolic characteristics (Maracaibo, Venezuela, 2015).

                                    HOMA2-IR \< 2    HOMA2-IR ≥ 2   *p* ^*∗*^   *χ* ^2^(*p*)            
  -------------------------------- ---------------- --------------- ----------- -------------- -------- -----------------------------
  *Body Mass Index (kg/m* ^*2*^)                                                                        *232.022 (\<0.001)*
   ≤24.9                           456              73.3            166         26.7           \<0.05    
   25--29.9                        409              57.4            305         42.6           \<0.05    
   ≥30                             214              31.2            469         68.8           \<0.05    
                                                                                                        
  *High TAG* ^‡^                                                                                        *83.47 (5.42 × 10* ^−*20*^)
   Absent                          872              59.8            587         40.2           \<0.05    
   Present                         211              37.2            356         62.8           \<0.05    
                                                                                                        
  *Low HDL-C* ^‡^                                                                                       *38.27 (6.15 × 10* ^−*10*^)
   Absent                          530              61.4            333         38.6           \<0.05    
   Present                         553              47.5            610         52.5           \<0.05    
                                                                                                        
  *Elevated WC* ^*∗*^                                                                                   *198.75 (\<0.001)*
   Absent                          689              63.7            304         32.3           \<0.05    
   Present                         393              36.3            638         67.7           \<0.05    
                                                                                                        
  *JNC-8 classification*                                                                                *42.83 (\<0.001)*
   Normotensive                    484              61              309         39             \<0.05    
   Prehypertensive                 402              52.5            363         47.5           NS        
   Hypertensive                    197              42.1            271         57.9           \<0.05    
                                                                                                        
  *Glycemic status* ^*¥*^                                                                               *155.37 (\<0.001)*
   Normoglycemic                   892              61.9            550         38.1           \<0.05    
   Impaired fasting glycemia       152              37.6            252         62.4           \<0.05    
   Type 2 diabetes mellitus        38               21.3            140         78.7           \<0.05    

^*∗*^ *Z* test for proportions; *χ* ^2^: Pearson\'s Chi-squared test.

TAG: triacylglycerides; HDL-C: high-density lipoprotein-cholesterol; WC: waist circumference.

^‡^ *IDF/AHA/NHLBI/WHF/IAS/IASO*2009 consensus criteria.

^*∗*^Females ≥ 90 cm; males ≥ 95 cm.

^*¥*^ *ADA* 2014 classification.

###### 

Biologic and anthropometric characteristics in the general population by insulin resistance status (Maracaibo, Venezuela, 2015).

                                 HOMA2-IR \< 2 (*n* = 1083)   HOMA2-IR ≥ 2 (*n* = 943)   *p* ^*∗*^
  ------------------------------ ---------------------------- -------------------------- ----------------
  Age (years)^a^                 38.48 ± 15.50                41.09 ± 15.11              3.15 × 10^−5^
  Body Mass Index (kg/m^2^)^a^   26.39 ± 5.24                 30.60 ± 6.52               7.13 × 10^−55^
  Waist circumference (cm)^a^    89.92 ± 12.68                100.34 ± 16.6              4.49 × 10^−54^
  Fasting glycemia (mg/dL)^a^    91.88 ± 20.99                107.48 ± 50.78             3.41 × 10^−39^
  Fasting insulin (*µ*U/mL)^a^   8.80 ± 2.70                  21.46 ± 10.15              \<0.001
  HOMA2-IR^a^                    1.31 ± 0.40                  3.24 ± 1.47                \<0.001
  Total cholesterol (mg/dL)^a^   186.91 ± 45.67               196.87 ± 46.31             2.39 × 10^−7^
  Triacylglycerides (mg/dL)^a^   110.70 ± 76.27               154.48 ± 122.02            5.45 × 10^−29^
  LDL-C (mg/dL)^a^               118.80 ± 38.06               125.25 ± 38.84             \<0.001
  HDL-C (mg/dL)^a^               45.90 ± 12.58                41.97 ± 10.95              3.67 × 10^−14^
  Systolic BP (mmHg)^a^          117.91 ± 16.57               121.96 ± 17.08             2.33 × 10^−8^
  Diastolic BP (mmHg)^a^         75.75 ± 10.99                79.05 ± 11.44              2.93 × 10^−11^
  hs-CRP (mg/dL)^b^              0.313 (0.086--0.622)         0.420 (0.154--0.942)       4.51 × 10^−7^

LDL-C: low-density lipoprotein-cholesterol; HDL-C: high-density lipoprotein-cholesterol; BP: blood pressure; hs-CRP: High-Sensitivity C-Reactive Protein.

^a^Normally distributed variable, expressed as mean ± standard deviation; ^b^nonnormally distributed variable, expressed as median (25th percentile--75th percentile).

^*∗*^Student\'s *t*-test was used for normally distributed variables; Mann-Whitney *U* test was used for nonnormally distributed variables.

###### 

Sociodemographic and metabolic risk factors associated with insulin resistance (Maracaibo, Venezuela, 2015).

                                                                    *Model 1* ^*∗*^     *Model 2* ^*∗*^                       
  ------------------------------------ ------------------- -------- ------------------- ----------------- ------------------- --------
  *Gender*                                                                                                                     
   Males                               1.00                ---      1.00                ---               1.00                ---
   Females                             1.01 (0.85--1.21)   0.89     1.29 (1.02--1.65)   0.04              1.33 (1.04--1.71)   0.02
                                                                                                                              
  *Age groups (years)*                                                                                                         
   \<30                                1.00                ---      1.00                ---               1.00                ---
   30--59                              1.48 (1.22--1.80)   \<0.01   0.65 (0.50--0.85)   \<0.01            0.64 (0.49--0.84)   \<0.01
   ≥60                                 1.50 (1.11--2.02)   \<0.01   0.42 (0.28--0.65)   \<0.01            0.42 (0.27--0.66)   \<0.01
                                                                                                                              
  *Occupational status*                                                                                                        
   Unemployed                          1.00                ---      1.00                ---               1.00                ---
   Employed                            1.31 (1.09--1.58)   \<0.01   1.45 (1.15--1.83)   \<0.01            1.42 (1.12--1.80)   \<0.01
                                                                                                                              
  *Leisure-domain physical activity*                                                                                           
   Inactive                            1.00                ---      1.00                ---               1.00                ---
   Very low                            0.99 (0.71--1.37)   0.93     1.25 (0.85--1.86)   0.24              1.29 (0.87--1.93)   0.21
   Low                                 0.73 (0.53--1.01)   0.06     0.71 (0.48--1.04)   0.07              0.70 (0.47--1.04)   0.08
   Moderate                            0.69 (0.49--0.97)   0.04     0.76 (0.51--1.14)   0.17              0.72 (0.48--1.09)   0.12
   High                                0.63 (0.45--0.89)   \<0.01   0.69 (0.46--1.03)   0.07              0.63 (0.41--0.95)   0.03
   Very high                           0.53 (0.38--0.74)   \<0.01   0.77 (0.52--1.15)   0.19              0.80 (0.54--1.20)   0.28
                                                                                                                              
  *Alcohol intake*                                                                                                             
   Absent                              1.00                ---      1.00                ---               1.00                ---
   Present                             1.21 (1.00--1.47)   0.05     1.41 (1.10--1.79)   \<0.01            1.44 (1.12--1.84)   \<0.01
                                                                                                                              
  *High TAG* ^‡^                                                                                                               
   Absent                              1.00                ---      1.00                ---               1.00                ---
   Present                             2.51 (2.05--3.06)   \<0.01   1.77 (1.38--2.27)   \<0.01            1.76 (1.36--2.29)   \<0.01
                                                                                                                              
  *Low HDL-C* ^‡^                                                                                                              
   Absent                              1.00                ---      1.00                ---               1.00                ---
   Present                             1.76 (1.47--2.10)   \<0.01   1.31 (1.06--1.64)   0.01              1.33 (1.06--1.66)   0.01
                                                                                                                              
  *Elevated waist circumference*                                                                                               
   Absent                              1.00                ---      1.00                ---               1.00                ---
   Present                             3.68 (3.06--4.42)   \<0.01   1.31 (0.98--1.76)   0.07              1.28 (0.95--1.73)   0.11
                                                                                                                              
  *JNC-8 classification*                                                                                                       
   Normotensive                        1.00                ---      1.00                ---               1.00                ---
   Prehypertensive                     1.41 (1.16--1.73)   \<0.01   0.96 (0.75--1.22)   0.73              0.96 (0.75--1.23)   0.75
   Hypertensive                        2.16 (1.71--2.72)   \<0.01   0.99 (0.73--1.37)   0.99              1.06 (0.77--1.46)   0.73
                                                                                                                              
  *Body Mass Index (kg/m* ^*2*^)                                                                                               
   ≤24.9                               1.00                ---      1.00                ---               1.00                ---
   25--29.9                            2.04 (1.62--2.57)   \<0.01   1.90 (1.41--2.55)   \<0.01            1.93 (1.43--2.61)   \<0.01
   ≥30                                 6.05 (4.76--7.69)   \<0.01   4.33 (2.97--6.29)   \<0.01            4.40 (2.99--6.47)   \<0.01
                                                                                                                              
  *Glycemic status* ^*¥*^                                                                                                      
   Normoglycemic                       1.00                ---      1.00                ---               1.00                ---
   Impaired fasting glycemia           2.69 (2.14--3.38)   \<0.01   2.43 (1.87--3.15)   \<0.01            2.44 (1.88--3.17)   \<0.01
   Type 2 diabetes mellitus            5.98 (4.11--8.68)   \<0.01   4.62 (2.71--7.88)   \<0.01            ---                 ---

^a^Confidence interval (95%); ^b^significance.

Model 1: adjusted for gender, age groups, ethnic groups, socioeconomic status, educational status, marital status, occupational status, diabetes mellitus family history, alcohol intake, smoking habits, leisure-domain physical activity, glycemic status, presence of high TAG, low HDL-C, and elevated waist circumference, BMI classification and JNC-8 classification.

Model 2: excluding diabetic subjects.

^*¥*^ *ADA* 2014 classification.

^‡^ *IDF/AHA/NHLBI/WHF/IAS/IASO*2009 consensus criteria.

[^1]: Academic Editor: Gerardo E. Guillén Nieto
